A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
Emily ReeveFrank MoriartyRayan NahasJustin P TurnerLisa Kouladjian O'DonnellSarah Nicole HilmerPublished in: Expert opinion on drug safety (2017)
More research is needed into the safety concerns of deprescribing, however, avenues exist during drug development and post-marketing surveillance to gain knowledge on this topic. Questions remain about when it is suitable to discontinue certain medications/medication classes and there is uncertainty about the harms and benefits of both medication continuation and discontinuation in complex older adults.